0
     

Report Added
Report already added
Viral Vectors Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Viral Vectors Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Viral Vectors market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Viral Vectors market segmented into
Retroviral Vectors
Lentiviral Vectors
Adenoviral Vectors
Herpes Simplex Virus Vectors
Chimeric Viral Vectors
Others

Based on the end-use, the global Viral Vectors market classified into
Cancers
Inherited Disorders
Viral Infections
Others

Based on geography, the global Viral Vectors market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
VGXI
PlasmidFactory
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL VIRAL VECTORS INDUSTRY
2.1 Summary about Viral Vectors Industry
2.2 Viral Vectors Market Trends
2.2.1 Viral Vectors Production & Consumption Trends
2.2.2 Viral Vectors Demand Structure Trends
2.3 Viral Vectors Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Retroviral Vectors
4.2.2 Lentiviral Vectors
4.2.3 Adenoviral Vectors
4.2.4 Herpes Simplex Virus Vectors
4.2.5 Chimeric Viral Vectors
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Cancers
4.3.2 Inherited Disorders
4.3.3 Viral Infections
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Retroviral Vectors
5.2.2 Lentiviral Vectors
5.2.3 Adenoviral Vectors
5.2.4 Herpes Simplex Virus Vectors
5.2.5 Chimeric Viral Vectors
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Cancers
5.3.2 Inherited Disorders
5.3.3 Viral Infections
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Retroviral Vectors
6.2.2 Lentiviral Vectors
6.2.3 Adenoviral Vectors
6.2.4 Herpes Simplex Virus Vectors
6.2.5 Chimeric Viral Vectors
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Cancers
6.3.2 Inherited Disorders
6.3.3 Viral Infections
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Retroviral Vectors
7.2.2 Lentiviral Vectors
7.2.3 Adenoviral Vectors
7.2.4 Herpes Simplex Virus Vectors
7.2.5 Chimeric Viral Vectors
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Cancers
7.3.2 Inherited Disorders
7.3.3 Viral Infections
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Retroviral Vectors
8.2.2 Lentiviral Vectors
8.2.3 Adenoviral Vectors
8.2.4 Herpes Simplex Virus Vectors
8.2.5 Chimeric Viral Vectors
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Cancers
8.3.2 Inherited Disorders
8.3.3 Viral Infections
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Retroviral Vectors
9.2.2 Lentiviral Vectors
9.2.3 Adenoviral Vectors
9.2.4 Herpes Simplex Virus Vectors
9.2.5 Chimeric Viral Vectors
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Cancers
9.3.2 Inherited Disorders
9.3.3 Viral Infections
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 BioReliance
10.1.2 Cobra Biologics
10.1.3 Oxford BioMedica
10.1.4 UniQure
10.1.5 FinVector
10.1.6 MolMed
10.1.7 MassBiologics
10.1.8 Richter-Helm
10.1.9 FUJIFILM Diosynth Biotechnologies
10.1.10 Lonza
10.1.11 Aldevron
10.1.12 Eurogentec
10.1.13 Cell and Gene Therapy Catapult
10.1.14 Biovian
10.1.15 Brammer Bio
10.1.16 VGXI
10.1.17 PlasmidFactory
10.2 Viral Vectors Sales Date of Major Players (2017-2020e)
10.2.1 BioReliance
10.2.2 Cobra Biologics
10.2.3 Oxford BioMedica
10.2.4 UniQure
10.2.5 FinVector
10.2.6 MolMed
10.2.7 MassBiologics
10.2.8 Richter-Helm
10.2.9 FUJIFILM Diosynth Biotechnologies
10.2.10 Lonza
10.2.11 Aldevron
10.2.12 Eurogentec
10.2.13 Cell and Gene Therapy Catapult
10.2.14 Biovian
10.2.15 Brammer Bio
10.2.16 VGXI
10.2.17 PlasmidFactory
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Viral Vectors Product Type Overview
2.Table Viral Vectors Product Type Market Share List
3.Table Viral Vectors Product Type of Major Players
4.Table Brief Introduction of BioReliance
5.Table Brief Introduction of Cobra Biologics
6.Table Brief Introduction of Oxford BioMedica
7.Table Brief Introduction of UniQure
8.Table Brief Introduction of FinVector
9.Table Brief Introduction of MolMed
10.Table Brief Introduction of MassBiologics
11.Table Brief Introduction of Richter-Helm
12.Table Brief Introduction of FUJIFILM Diosynth Biotechnologies
13.Table Brief Introduction of Lonza
14.Table Brief Introduction of Aldevron
15.Table Brief Introduction of Eurogentec
16.Table Brief Introduction of Cell and Gene Therapy Catapult
17.Table Brief Introduction of Biovian
18.Table Brief Introduction of Brammer Bio
19.Table Brief Introduction of VGXI
20.Table Brief Introduction of PlasmidFactory
21.Table Products & Services of BioReliance
22.Table Products & Services of Cobra Biologics
23.Table Products & Services of Oxford BioMedica
24.Table Products & Services of UniQure
25.Table Products & Services of FinVector
26.Table Products & Services of MolMed
27.Table Products & Services of MassBiologics
28.Table Products & Services of Richter-Helm
29.Table Products & Services of FUJIFILM Diosynth Biotechnologies
30.Table Products & Services of Lonza
31.Table Products & Services of Aldevron
32.Table Products & Services of Eurogentec
33.Table Products & Services of Cell and Gene Therapy Catapult
34.Table Products & Services of Biovian
35.Table Products & Services of Brammer Bio
36.Table Products & Services of VGXI
37.Table Products & Services of PlasmidFactory
38.Table Market Distribution of Major Players
39.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
40.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
41.Table Global Viral Vectors Market Forecast (Million USD) by Region 2021f-2026f
42.Table Global Viral Vectors Market Forecast (Million USD) Share by Region 2021f-2026f
43.Table Global Viral Vectors Market Forecast (Million USD) by Demand 2021f-2026f
44.Table Global Viral Vectors Market Forecast (Million USD) Share by Demand 2021f-2026f

Report Title: Viral Vectors Market Status and Trend Analysis 2017-2026 (COVID-19 Version)


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW